Eli Lilly and Company (LLY) announced a significant $4.5 billion investment for the establishment of the Lilly Medicine Foundry in Indiana to advance drug production and innovation. This facility will enable the development of new methods for making its drugs and also scale up the supply of medicines for clinical trials for Lilly’s growing pipeline. This one-of-a-kind facility, which combines research and manufacturing in a single location, will open in 2027.The Medicine Foundry, which is expected to create ...